arrow
K

Kuaile Zhao

复旦大学
H指数:44
被引数:8,974

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study

免疫疗法背景下胸部放射治疗在多发性转移性食管鳞状细胞癌中的作用:一项多中心队列研究

2026-02-120
PRE
Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trials

食管鳞状细胞癌的术后化放疗:来自ESO-Shanghai 17和联合分析的II期临床试验结果

2025-11-210
OAAI
Validation and refinement of the 8th edition of the AJCC staging system for esophageal squamous cell carcinoma treated with definitive IMRT or chemo-IMRT: a Chinese multi-institutional retrospective study

AJCC第8版食管鳞状细胞癌分期系统在根治性IMRT或放化疗方案治疗患者中的验证与优化:一项中国多中心回顾性研究

2025-11-180
OAAI
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study

比较免疫化疗联合或不联合放射治疗局限于非区域淋巴结转移的IVB期食管鳞状细胞癌的疗效:一项多中心倾向性评分匹配研究

2025-11-180
OAAI
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study

中国晚期/复发或转移性食管鳞状细胞癌患者一线派姆单抗联合化疗的有效性和安全性: 一项真实世界的多中心研究

2024-11-190
OAAI
Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial

camrelizumab联合化疗治疗未经治疗的晚期或转移性食管鳞状细胞癌的最终分析: ESCORT-1st试验

MED
IF11.8
2024-09-011
PRE